JOSÉ LUIS PÉREZ CASTRILLÓN-rekin lankidetzan egindako argitalpenak (27)

2024

  1. Genistein supplementation has no effects on vitamin D levels in healthy Spanish postmenopausal women

    International Journal for Vitamin and Nutrition Research, Vol. 94, Núm. 3-4, pp. 171-176

2023

  1. Influence of non-osteoporotic treatments in patients on active anti-osteoporotic therapy: evidence from the OSTEOMED registry

    European Journal of Clinical Pharmacology, Vol. 79, Núm. 10, pp. 1333-1339

  2. Speech therapy and hyperbaric oxygen for aphasia after carbon monoxide intoxication

    Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc, Vol. 50, Núm. 1, pp. 3-7

2022

  1. Molecular Mechanisms Involved in Hypoxia-Induced Alterations in Bone Remodeling

    International Journal of Molecular Sciences, Vol. 23, Núm. 6

  2. Vitamin D Receptor (VDR) Gene Polymorphisms Modify the Response to Vitamin D Supplementation: A Systematic Review and Meta-Analysis

    Nutrients, Vol. 14, Núm. 2

2021

  1. Fracture risk predictors of a postmenopausal female population by binary statistical procedure CART

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 12, Núm. 4, pp. 122-128

2020

  1. Association between Bat Vitamin D Receptor 3′ Haplotypes and Vitamin D Levels at Baseline and a Lower Response after Increased Vitamin D Supplementation and Exposure to Sunlight

    International Journal for Vitamin and Nutrition Research, Vol. 90, Núm. 3-4, pp. 290-294

  2. Relationship between insulin resistance (HOMA-IR), trabecular bone score (TBS), and three-dimensional dual-energy X-ray absorptiometry (3D-DXA) in non-diabetic postmenopausal women

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-10

2019

  1. Central sensitization syndromes: Towards to the structuring of a multidisciplinary concept

    Medicina Clinica

  2. Estrogen receptor genes polymorphisms determine serum lipid profile in healthy postmenopausal women treated with calcium, vitamin D, and genistein

    Journal of Cellular Biochemistry, Vol. 120, Núm. 8, pp. 13115-13120

  3. Nutrigenetics of Bone Health

    Principles of Nutrigenetics and Nutrigenomics: Fundamentals of Individualized Nutrition (Elsevier), pp. 377-382

2018

  1. Role of Bone Morphogenetic Protein 2 Polymorphisms in Bone Mineral Density after the Start of Treatment with Atorvastatin

    Basic and Clinical Pharmacology and Toxicology, Vol. 123, Núm. 6, pp. 766-769

  2. The Effect of Genistein Supplementation on Vitamin D Levels and Bone Turnover Markers during the Summer in Healthy Postmenopausal Women: Role of Genotypes of Isoflavone Metabolism

    Journal of Nutrigenetics and Nutrigenomics, Vol. 10, Núm. 5-6, pp. 139-145

  3. Toxic diseases: gas and metal poisonings

    Medicine (Spain), Vol. 12, Núm. 69, pp. 4027-4042

2016

  1. Protocolo de tratamiento de las alteraciones de la vitamina D

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 16, pp. 930-933

2015

  1. Ankle-brachial index, risk of clinical fractures, mortality and low bone mass in nursing home residents

    European Review for Medical and Pharmacological Sciences, Vol. 19, Núm. 9, pp. 1577-1582

  2. Prospective observational study to evaluate risk factors for falls in institutionalized elderly people: The role of cystatin C

    Aging Clinical and Experimental Research, Vol. 27, Núm. 4, pp. 419-424

2014

  1. Effect of two types of bariatric surgery (gastrojejunal bypass and sleeve gastroplasty) on gene expression of bone remodeling markers in Goto-Kakizaki Rats

    Obesity Surgery, Vol. 24, Núm. 1, pp. 37-41

  2. Polymorphisms of the farnesyl diphosphate synthase gene modulate bone changes in response to atorvastatin

    Rheumatology International, Vol. 34, Núm. 8, pp. 1073-1077

2013

  1. Treatment of osteoporosis and hip fractures in a Spanish health area

    European Review for Medical and Pharmacological Sciences, Vol. 17, Núm. 2, pp. 266-268